A RANDOMIZED, CONTROLLED PHASE III TRIAL OF SORAFENIB WITH OR WITHOUT CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (STAH)

被引：2
|
作者：
Park, J. -W. [1 ]
Kim, Y. J. [2 ]
Kim, D. Y. [3 ]
Bae, S. H. [4 ]
Yeon, J. E. [5 ]
Han, S. Y. [6 ]
Hwang, J. S. [7 ]
Lee, Y. -J. [8 ]
Cheong, J. Y. [9 ]
Kwon, O. S. [10 ]
Kim, H. Y. [11 ]
Lee, H. C. [12 ]
Heo, J. [13 ]
Kim, B. H. [1 ]
Paik, S. W. [14 ]
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[3] Severance Hosp, Seoul, South Korea
[4] Catholic Univ Hosp Korea, Seoul, South Korea
[5] Korea Univ, Guro Hosp, Seoul, South Korea
[6] Dong A Univ, Med Ctr, Busan, South Korea
[7] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea
[8] Busan Paik Hosp, Busan, South Korea
[9] Ajou Univ Hosp, Suwon, South Korea
[10] Gachon Univ, Gil Hosp, Inchon, South Korea
[11] Boramae Med Ctr, Seoul, South Korea
[12] Asan Med Ctr, Seoul, South Korea
[13] Busan Natl Univ Hosp, Busan, South Korea
[14] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31514-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1335
引用
收藏
页码：S857 / S857
页数：1
相关论文
共 50 条
  • [1] Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
    Park, Joong-Won
    Kim, Yoon Jun
    Kim, Do Young
    Bae, Si-Hyun
    Paik, Seung Woon
    Lee, Youn-Jae
    Kim, Hwi Young
    Lee, Han Chu
    Han, Sang Young
    Cheong, Jae Youn
    Kwon, Oh Sang
    Yeon, Jong Eun
    Kim, Bo Hyun
    Hwang, Jaeseok
    JOURNAL OF HEPATOLOGY, 2019, 70 (04) : 684 - 691
  • [2] Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
    Park, J. -W.
    Kim, Y. J.
    Kim, D. Y.
    Bae, S. H.
    Paik, S. W.
    Lee, Y. -J.
    Lee, D.
    Lee, H. C.
    Han, S. Y.
    Cheong, J. Y.
    Kwon, O. S.
    Yeon, J. E.
    Kim, B. H.
    Hwang, J. -S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S2 - S2
  • [3] Sorafenib with or without concurrent transarterial chemoembolization in hepatocellular carcinoma: a cautionary comment of STAH trial
    Chen, Jia-Hao
    Liu, Xu
    Chen, Kang
    Hu, Xiao-Yin
    Xiang, Bang-De
    Yuan, Wei-Ping
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (01) : 400 - 401
  • [4] Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial
    Kudo, Masatoshi
    Han, Guohong
    Finn, Richard S.
    Poon, Ronnie T. P.
    Blanc, Jean-Frederic
    Yan, Lunan
    Yang, Jijin
    Lu, Ligong
    Tak, Won-Young
    Yu, Xiaoping
    Lee, Joon-Hyeok
    Lin, Shi-Ming
    Wu, Changping
    Tanwandee, Tawesak
    Shao, Guoliang
    Walters, Ian B.
    Dela Cruz, Christine
    Poulart, Valerie
    Wang, Jian-Hua
    HEPATOLOGY, 2014, 60 (05) : 1697 - 1707
  • [5] Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
    Okusaka, Takuji
    Kasugai, Hiroshi
    Shioyama, Yasukazu
    Tanaka, Katsuaki
    Kudo, Masatoshi
    Saisho, Hiromitsu
    Osaki, Yukio
    Sata, Michio
    Fujiyama, Shigetoshi
    Kumada, Takashi
    Sato, Keiko
    Yamamoto, Seiichiro
    Hinotsu, Shiro
    Sato, Tosiya
    JOURNAL OF HEPATOLOGY, 2009, 51 (06) : 1030 - 1036
  • [6] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
  • [7] Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
    Ha, Yeonjung
    Lee, Danbi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Park, Sook Ryun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    Kim, Kang Mo
    ONCOTARGET, 2016, 7 (45) : 74303 - 74313
  • [8] Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.
    Kuang, Ming
    Peng, Zhenwei
    Fan, Wenzhe
    Liu, Zelong
    Xiao, Han
    Tu, Jianfei
    Tang, Rong
    Huang, Zhen
    Cheng, Yu
    Li, Fuliang
    Lu, Mingjian
    Li, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 493 - 493
  • [9] SORAFENIB WITH OR WITHOUT TRANSARTERIAL CHEMOEMBOLIZATION PLUS RADIOFREQUENCY ABLATION FOR ADVANCED RECURRENT HEPATOCELLULAR CARCINOMA
    Xiao, Han
    Zhang, Ning
    Xu, Lixia
    Kuang, Ming
    GASTROENTEROLOGY, 2018, 154 (06) : S1236 - S1236
  • [10] PHASE II STUDY OF THE CONCURRENT COMBINATION OF CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION AND SORAFENIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Park, Joong-Won
    Kim, Hwi Young
    Ahn, Sang Bu
    Choi, Joon-Il
    Woo, Sang Myung
    Kim, Hyun-Beom
    KoH, Young Hwan
    Nam, Byung Ho
    HEPATOLOGY, 2011, 54 : 1443A - 1443A
12345